Advanced Search

 

Study ID Status Title Patient Level Data
29060/189 Completed A Double-Blind Randomized Study to Provide Safety Information on Switching Fluoxetine-Treated Patients to Paroxetine without an Intervening Washout Period
29060/190 Completed A Double-Blind, Comparative, Placebo-Controlled Trial of Paroxetine in the Prevention of Recurrent Depression
29060/197 Completed A Double-Blind Comparison of the Efficacy and Tolerability of Paroxetine and Imipiramine in the Treatment of Depression and Behavioural Disturbance Associated with Dementia
29060/201 Completed A Double-Blind, Placebo Controlled Study, to Assess the Efficacy of Paroxetine in the Prevention of Relapse Following Detoxification in Alcoholics
29060/222 Completed A Double-Blind, Placebo-Controlled, Continuation of Study 29060/120 to Assess the Long Term Safety and Efficacy of Paroxetine in the Treatment of Panic Disorder and its Role in the Prevention of Relapse/Recurrence
29060/223 Completed A Double-Blind, Multicentered, Flexible-Dose Study of Paroxetine, Alprazolam and Placebo in the Treatment of Panic Disorder Study Listed on ClinicalStudyDataRequest.com
29060/228 Completed A Long-Term Extension of a Double-Blind, Placebo -Controlled Comparative Study of Paroxetine and Clomipramine in the Treatment of Panic Disorder
29060/238 Completed A study to determine the steady-state pharmacokinetics of paroxetine (20 mg o.d. p.o. for 18 days) in subjects with impaired renal function.
29060/239 Completed A Randomized, Comparative Study of Paroxetine in the Treatment of Depression as Used in a Clinical Practice Setting
29060/239_1 Completed A Randomized, Comparative Study of Paroxetine in the Treatment of Depression as Used in a Clinical Practice Setting
29060/241 Completed A Double-Blind Study to Compare the Maintenance of Efficacy and Relapse Rates in Patients with Obsessive Compulsive Disorder who Responded to Paroxetine, Clomipramine or Placebo in the Short Term Study 136.
29060/243 Completed An open study to investigate the effects of repeated dosing of paroxetine (20 mg OD for 38 days) on the pharmacokinetics and metabolism of a single dose of desipramine (100 mg) in healthy volunteer subjects
29060/245 Completed A Double-Blind, Multicentre Study in Primary Care Comparing Paroxetine and Clomipramine in Patients with Depression with Associated Anxiety
29060/251 Completed A Double-Blind, Randomized Trial of Paroxetine Versus Placebo In Patients With Depression Accompanied by Anxiety Study Listed on ClinicalStudyDataRequest.com
29060/252 Completed A Multicentre Open Study to Investigate the Safety and Efficacy of Paroxetine in the Treatment of Depressed Patients
29060/253 Completed An Open Pharmacokinetic and Pharmacodynamic Study of Paroxetine (20 – 50mg daily) in the Treatment of Major Depressive Disorder (DSM III)
29060/256 Completed A Study of the Efficacy and Safety of Paroxetine in Subjects with Depression
29060/257 Completed An Open Multicentre Study to Assess the Safety and Efficacy of Paroxetine in Patients with Depression
29060/258 Completed An Early Clinical Phase II Evaluation of Paroxetine, a New Product and 5-HT Uptake Inhibitor in Patients with Depressive Illness
29060/259 Completed Paroxetine, a Selective Serotonin Uptake Inhibitor in the Treatment of Depressive Illness – a Clinical Phase II Study
29060/260 Completed Paroxetine in the treatment of depression – a randomised comparison with amitriptyline.
29060/261 Completed A Double-Blind, Comparative Study of Paroxetine and Clomipramine to Assess Efficacy and to Evaluate the Correlation Between Plasma Concentration and Effect
29060/268 Completed A study to assess the efficacy and safety of paroxetine in patients with depression
29060/270 Completed Comparison of the effects of single doses of paroxetine, amitriptyline and placebo on systolic time intervals in volunteers
29060/272 Completed A Comparison of the Efficacy and Tolerance of Paroxetine and Amitriptyline in the Treatment of Depression. A Double-Blind, Parallel Study

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.